Silencing an oncogenic microRNA, miR-21, in sunitinib-resistant glioblastoma cells led to an increase in the apoptotic rate of cancer cells by overexpressing PTEN and PDCD4, as well as increased activity of caspase 3/7, reversing MDR in these cells [144]. The gene discussed is CASP3; the disease is glioblastoma.